| Influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course L Cavagna, E Trallero-Araguás, F Meloni, I Cavazzana, J Rojas-Serrano, ... Journal of clinical medicine 8 (11), 2013, 2019 | 171 | 2019 |
| Unveiling the efficacy, safety, and tolerability of anti-interleukin-1 treatment in monogenic and multifactorial autoinflammatory diseases A Bettiol, G Lopalco, G Emmi, L Cantarini, ML Urban, A Vitale, N Denora, ... International journal of molecular sciences 20 (8), 1898, 2019 | 72 | 2019 |
| The autoinflammatory side of recurrent pericarditis: Enlightening the pathogenesis for a more rational treatment G Lopalco, D Rigante, L Cantarini, M Imazio, A Lopalco, G Emmi, ... Trends in Cardiovascular Medicine 31 (5), 265-274, 2021 | 44 | 2021 |
| Influence of baseline modified Rheumatic Disease Comorbidity Index (mRDCI) on drug survival and effectiveness of biological treatment in patients affected with Rheumatoid … F Iannone, F Salaffi, M Fornaro, M Di Carlo, S Gentileschi, L Cantarini, ... European journal of clinical investigation 48 (11), e13013, 2018 | 44 | 2018 |
| Lipids and atherogenic indices fluctuation in rheumatoid arthritis patients on long-term tocilizumab treatment F Cacciapaglia, MG Anelli, A Rinaldi, M Fornaro, G Lopalco, C Scioscia, ... Mediators of inflammation 2018, 2018 | 39 | 2018 |
| Preliminary data on post market safety profiles of COVID 19 vaccines in rheumatic diseases: assessments on various vaccines in use, different rheumatic disease subtypes, and … C Rotondo, FP Cantatore, M Fornaro, R Colia, G Busto, V Rella, ... Vaccines 9 (7), 730, 2021 | 37 | 2021 |
| Comorbid fibromyalgia impairs the effectiveness of biologic drugs in patients with psoriatic arthritis F Iannone, M Nivuori, M Fornaro, V Venerito, F Cacciapaglia, G Lopalco Rheumatology 59 (7), 1599-1606, 2020 | 32 | 2020 |
| Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies. L Cavagna, F Meloni, A Meyer, G Sambataro, M Belliato, E De Langhe, ... Clinical and experimental rheumatology 40 (2), 274-283, 2022 | 29 | 2022 |
| Comparison of early vs. delayed Anakinra treatment in patients with adult onset Still's disease and effect on clinical and laboratory outcomes A Vitale, G Cavalli, P Ruscitti, J Sota, S Colafrancesco, R Priori, G Valesini, ... Frontiers in Medicine 7, 42, 2020 | 26 | 2020 |
| Immunogenicity of BNT162b2 mRNA SARS-CoV-2 vaccine in patients with psoriatic arthritis on TNF inhibitors V Venerito, P Stefanizzi, M Fornaro, F Cacciapaglia, S Tafuri, S Perniola, ... RMD open 8 (1), e001847, 2022 | 25 | 2022 |
| A Bayesian mixed treatment comparison of efficacy of biologics and small molecules in early rheumatoid arthritis V Venerito, G Lopalco, F Cacciapaglia, M Fornaro, F Iannone Clinical Rheumatology 38 (5), 1309-1317, 2019 | 23 | 2019 |
| Long-term efficacy of adding intravenous immunoglobulins as treatment of refractory dysphagia related to myositis: a retrospective analysis M Giannini, ML Fiorella, M Tampoia, F Girolamo, M Fornaro, A Amati, ... Rheumatology 60 (3), 1234-1242, 2021 | 22 | 2021 |
| A machine learning approach for predicting sustained remission in rheumatoid arthritis patients on biologic agents V Venerito, O Angelini, M Fornaro, F Cacciapaglia, G Lopalco, F Iannone JCR: Journal of Clinical Rheumatology 28 (2), e334-e339, 2022 | 20 | 2022 |
| Efficacy of baricitinib on refractory skin papulosquamous rash in a patient with systemic lupus erythematosus M Fornaro, L Coladonato, V Venerito, F Cacciapaglia, G Lopalco, ... Rheumatology 59 (5), 1188-1188, 2020 | 20 | 2020 |
| Severe muscle damage with myofiber necrosis and macrophage infiltrates characterize anti-Mi2 positive dermatomyositis M Fornaro, F Girolamo, L Cavagna, F Franceschini, M Giannini, A Amati, ... Rheumatology 60 (6), 2916-2926, 2021 | 18 | 2021 |
| Estimated 10-year cardiovascular risk in a large Italian cohort of rheumatoid arthritis patients: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group F Cacciapaglia, FR Spinelli, M Piga, GL Erre, G Sakellariou, A Manfredi, ... European Journal of Internal Medicine 96, 60-65, 2022 | 17 | 2022 |
| C-reactive protein and 10-year cardiovascular risk in rheumatoid arthritis GL Erre, F Cacciapaglia, G Sakellariou, A Manfredi, E Bartoloni, ... European Journal of Internal Medicine 104, 49-54, 2022 | 15 | 2022 |
| Body mass index and adipokines/cytokines dysregulation in systemic sclerosis F Iannone, E Praino, C Rotondo, D Natuzzi, R Bizzoca, N Lacarpia, ... Clinical & Experimental Immunology 206 (2), 153-160, 2021 | 15 | 2021 |
| Paradoxical pustular psoriasis in a patient with psoriatic arthritis on secukinumab treatment A Abbruzzese, V Venerito, G Lopalco, M Fornaro, M Giannotta, F Iannone JCR: Journal of Clinical Rheumatology 26 (6), e208-e209, 2020 | 15 | 2020 |
| Relapses of idiopathic inflammatory myopathies after vaccination against COVID-19: a real-life multicenter Italian study E Conticini, M d’Alessandro, S Grazzini, M Fornaro, D Sabella, G Lopalco, ... Internal and Emergency Medicine 17 (7), 1921-1928, 2022 | 13 | 2022 |
